QoL, global functioning and social adaptation of schizophrenic subjects treated with long-acting risperidone

被引：0
|
作者：
Golubovic, S. Tosic [1 ]
Sibinovic, V. S. [2 ]
Slavkovic, V. S. [2 ]
Zikic, Z. O. [1 ]
Gugleta, D. C. [2 ]
机构：
[1] Fac Med, Dept Psychiat, Nish, Serbia
[2] Psychiat Clin, Dept Psychiat, Nish, Serbia
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2010年 / 20卷
关键词：
D O I：
10.1016/S0924-977X(10)70733-1
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S494 / S494
页数：1
相关论文
共 50 条
  • [1] Service utilisation of schizophrenic patients treated with long-acting injectable risperidone in Taiwan
    Chang, H.
    Su, K.
    McCropne, P.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S446 - S447
  • [2] Psychopathology and global functioning in schizophrenic patients on depot antypsychotics and long-acting injectable risperidone:: A six month comparative study
    Intxausti, A.
    Morera, A. L.
    Gonzalez-Hernandez, C. C.
    Alonso-Diaz, D.
    Gonzalez-Brito, N.
    Hernandez-Garcia, D.
    Henry, M.
    Orozco, A.
    Diaz-Mesa, E.
    de Diego-Herrero, E.
    EUROPEAN PSYCHIATRY, 2007, 22 : S116 - S116
  • [3] Improvements in illness severity and functioning in schizophrenic patients switched to risperidone long-acting injection (RLAI)
    Peuskens, J.
    Povey, M.
    Diels, J.
    Van der Veken, J.
    Jacobs, A.
    VALUE IN HEALTH, 2006, 9 (06) : A320 - A320
  • [4] Efficacy and safety of long-acting risperidone in schizophrenic stable subjects durring 6 months period
    Gugleta, D. G.
    Slaykovic, Vs.
    Golubovic, S. T. G. Tosic
    Sibinovic, V. S.
    Stankovic, S. D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S496 - S496
  • [5] Variations in prolactin levels and related symptoms in schizophrenic patients treated with long-acting injectable risperidone
    Kalkavoura, C.
    Theodorou, A.
    Theodoropoulou, P.
    Tzebelikos, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S252 - S252
  • [6] QoL of schizophrenic inpatients treated with risperidone or haloperidol
    Vukic, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S441 - S442
  • [7] Prolactin response to oral and long-acting forms of risperidone in schizophrenic patients
    Duval, Fabrice
    Chokmani, Nessim
    Mokrani, Marie-Claude
    He, Jun
    Duarte-Garcia, Frederico
    Macher, Jean-Paul
    BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 83S - 83S
  • [8] Improvements in illness severity and functioning in patients with schizophrenia treated with risperidone long-acting injection in The Netherlands
    van Kooten, M.
    de Weg, H. Bij
    de Groot-Stam, E.
    Mulder, C. L.
    Povey, M.
    Manders, M.
    Lam, A.
    Zhao, Z.
    EUROPEAN PSYCHIATRY, 2008, 23 : S162 - S163
  • [9] Symptom control, functioning and satisfaction among Swiss patients treated with risperidone long-acting injectable
    Nick, Beat
    Vauth, Roland
    Braendle, Daniel
    Riecher-Roessler, Anita
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2006, 10 (03) : 174 - 181
  • [10] Improved symptom control, functioning and satisfaction in French patients treated with long-acting injectable risperidone
    Llorca, P. -M.
    Bouhours, P.
    Moreau-Mallet, V.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2008, 34 (02): : 170 - 178
12345